Fig. 5: The changes in Mki67 titer before and after treatment. | Genes & Immunity

Fig. 5: The changes in Mki67 titer before and after treatment.

From: Novel modulation of T effector memory cells-expressing CD45RA by prednisone in inoperable advanced type B thymoma patients

Fig. 5

Tumor tissues were marked by Mki67 antibodies in various pathological types of tissues by immunofluorescence. After treatment, the Mki67 level increased in one patient each for types A, AB, and B3, while it decreased in 1, 1, 3, and 2 patients respectively for types A, AB, B1, and B2. However, the changes in Mki67 in any of the groups were not statistically significant (P > 0.05).

Back to article page